Clinical Trial Update: Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating metformin to slow respiratory decline in idiopathic pulmonary fibrosis. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: NOT_YET_RECRUITING